Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes. - Wikidata - wikimedia - TriplyDB

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

http://www.wikidata.org/entity/Q37185312

about

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.Overexpression or silencing of FOXO3a affects proliferation of endothelial progenitor cells and expression of cell cycle regulatory proteins.PSF: nuclear busy-body or nuclear facilitator?Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs.P68 RNA helicase as a molecular target for cancer therapy.Role of p27Kip1 as a transcriptional regulator.

P2860

Q33660573-E7C5CB17-32C1-45B2-A1D5-40778D8FAEDA Q35219442-0B16D2E6-51E0-4A76-AF0A-AEF996A8D774 Q35772782-08BA8C13-3D7F-448A-AB8C-44D920ED51D4 Q36186117-FF8587E9-7A55-4F0F-B139-577FBD85AE10 Q36187896-50ECEB27-3A88-44E8-A3C3-B519E2FCEB0B Q37154185-259D221C-780F-41EC-90ED-2D970B81C24F Q37649607-768675E3-4B92-45B4-871E-2FD58E784AF5 Q38242524-A87CA93C-98DD-4BA7-8155-E561C9E82538 Q55074324-3E6DB5C5-4D28-4953-B5BC-2C152B640FE1

P2860

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

http://www.wikidata.org/entity/Q37185312

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@en

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@nl

type

label

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@en

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@nl

prefLabel

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@en

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@nl

P1433

Q37185312-A8982519-6F93-4E1E-AAB8-A1BCFDB04862

P1476

Q37185312-290DDA85-B303-4266-8297-AECA0A2692A0

P2093

Q37185312-78C73AED-998D-433C-A0DC-D60D87C27F7A

Q37185312-9112F8BF-79CE-4D60-8CCA-FC633D25D616

Q37185312-A9F38D45-EB27-4BE0-8459-95D529E9733D

Q37185312-BB0746C7-B234-49A6-AF0B-5C324996BAFF

Q37185312-D08ABD93-C401-4490-9A80-A2EC736C328C

Q37185312-DAD84895-9796-4128-ADC9-CD3E66437312

P2860

Q37185312-018CF77E-D587-4FB0-B291-065E20C05D9F

Q37185312-087A2E3A-A639-493A-85D7-F3BE0E5C9E9D

Q37185312-09987093-113A-4055-91AB-62C90C7D3075

Q37185312-09FBA92B-547A-4F2D-B6F3-44639E54EDE9

Q37185312-0AC05DBF-5857-40D4-834D-C151AB137615

Q37185312-0DE35EBA-0348-4B27-B87F-92CAE5689653

Q37185312-16C86AD3-30DD-459F-BF14-097C37F55024

Q37185312-24C105D4-E475-4C6E-A411-E7C6D0C7505F

Q37185312-2B4456B6-DA22-460F-AAC0-0D56CC3F2AB7

Q37185312-2D296E80-716C-42A4-9EDB-2E3C1A470B86

P304

Q37185312-D0AFE47D-E580-4D1B-8D3D-92B09CAC7FE3

P31

Q37185312-03BD6049-F2DB-4423-818C-1E886A61B887

P356

Q37185312-880EB77A-C060-4E35-8795-29A764271DE9

P407

Q37185312-2C04BB2A-17C3-4A41-AC03-85BFB25A7204

P433

Q37185312-93624EF5-D663-468A-852D-11590CD3DCAF

P478

Q37185312-07D9290C-BC33-4B9D-9E2E-6FF436EA7AD6

P577

Q37185312-1192C8A7-1510-49F4-BF51-834FFD3ECEB7

P5875

Q37185312-DB1987A2-80F6-4433-B5DB-DB5F7D0A5647

P698

Q37185312-5072074F-F956-4B70-A37C-2E06797F196E

P932

Q37185312-8D966B1F-B7D9-4863-BEBB-69222977C975

P356

P1433

P1476

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

@en

P2093

Bradley J Davis

http://www.w3.org/2001/XMLSchema#string

Brian K Law

http://www.w3.org/2001/XMLSchema#string

Mary E Law

http://www.w3.org/2001/XMLSchema#string

Patrick E Corsino

http://www.w3.org/2001/XMLSchema#string

Stephan C Jahn

http://www.w3.org/2001/XMLSchema#string

Thomas C Rowe

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication

Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions

p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2

Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing

Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication

BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

P304

3489-3501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BI400047U

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236579556

http://www.w3.org/2001/XMLSchema#string

P698

23627734

http://www.w3.org/2001/XMLSchema#string

P932

3778134

http://www.w3.org/2001/XMLSchema#string